<code id='1A87625983'></code><style id='1A87625983'></style>
    • <acronym id='1A87625983'></acronym>
      <center id='1A87625983'><center id='1A87625983'><tfoot id='1A87625983'></tfoot></center><abbr id='1A87625983'><dir id='1A87625983'><tfoot id='1A87625983'></tfoot><noframes id='1A87625983'>

    • <optgroup id='1A87625983'><strike id='1A87625983'><sup id='1A87625983'></sup></strike><code id='1A87625983'></code></optgroup>
        1. <b id='1A87625983'><label id='1A87625983'><select id='1A87625983'><dt id='1A87625983'><span id='1A87625983'></span></dt></select></label></b><u id='1A87625983'></u>
          <i id='1A87625983'><strike id='1A87625983'><tt id='1A87625983'><pre id='1A87625983'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:9113
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Arc Institute generative AI designs new CRISPR systems
          Arc Institute generative AI designs new CRISPR systems

          PatrickHsu,co-founderoftheArcInstitute,speaksduringtheSTATBreakthroughSummitWestinSanFranciscoThursd

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb